84 related articles for article (PubMed ID: 21326329)
1. Treatment of experimental autoimmune encephalomyelitis in SJL/J mice with a replicative HSV-1 vector expressing interleukin-5.
Nygårdas M; Aspelin C; Paavilainen H; Röyttä M; Waris M; Hukkanen V
Gene Ther; 2011 Jul; 18(7):646-55. PubMed ID: 21326329
[TBL] [Abstract][Full Text] [Related]
2. HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.
Furlan R; Bergami A; Brambilla E; Butti E; De Simoni MG; Campagnoli M; Marconi P; Comi G; Martino G
Gene Ther; 2007 Jan; 14(1):93-8. PubMed ID: 16929354
[TBL] [Abstract][Full Text] [Related]
3. Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simplex virus type 1 viral vector precludes experimental allergic encephalomyelitis.
Broberg E; Setälä N; Röyttä M; Salmi A; Erälinna JP; He B; Roizman B; Hukkanen V
Gene Ther; 2001 May; 8(10):769-77. PubMed ID: 11420640
[TBL] [Abstract][Full Text] [Related]
4. IL-4 is the key regulator in herpes simplex virus-based gene therapy of BALB/c experimental autoimmune encephalomyelitis.
Broberg EK; Salmi AA; Hukkanen V
Neurosci Lett; 2004 Jul; 364(3):173-8. PubMed ID: 15196670
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of Th2 responses to replicative herpes simplex virus type 1 vectors by immunomodulative chemotherapy.
Peltoniemi J; Broberg EK; Nygårdas M; Erälinna JP; Waris M; Hukkanen V
Int Immunopharmacol; 2006 May; 6(5):817-29. PubMed ID: 16546713
[TBL] [Abstract][Full Text] [Related]
6. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery.
Kennedy MK; Torrance DS; Picha KS; Mohler KM
J Immunol; 1992 Oct; 149(7):2496-505. PubMed ID: 1527389
[TBL] [Abstract][Full Text] [Related]
7. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.
Samoilova EB; Horton JL; Chen Y
Cell Immunol; 1998 Sep; 188(2):118-24. PubMed ID: 9756642
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.
Furlan R; Poliani PL; Marconi PC; Bergami A; Ruffini F; Adorini L; Glorioso JC; Comi G; Martino G
Gene Ther; 2001 Jan; 8(1):13-9. PubMed ID: 11402297
[TBL] [Abstract][Full Text] [Related]
9. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease.
Toft-Hansen H; Füchtbauer L; Owens T
Glia; 2011 Jan; 59(1):166-76. PubMed ID: 21046558
[TBL] [Abstract][Full Text] [Related]
11. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
[TBL] [Abstract][Full Text] [Related]
12. Treatment of experimental autoimmune encephalomyelitis with a neurotropic alphavirus vector expressing tissue inhibitor of metalloproteinase-2.
Nygårdas PT; Grönberg SA; Heikkilä J; Joronen K; Sorsa T; Hinkkanen AE
Scand J Immunol; 2004 Oct; 60(4):372-81. PubMed ID: 15379862
[TBL] [Abstract][Full Text] [Related]
13. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.
Renno T; Krakowski M; Piccirillo C; Lin JY; Owens T
J Immunol; 1995 Jan; 154(2):944-53. PubMed ID: 7814894
[TBL] [Abstract][Full Text] [Related]
14. Semliki Forest virus vectors expressing transforming growth factor beta inhibit experimental autoimmune encephalomyelitis in Balb/c mice.
Vähä-Koskela MJ; Kuusinen TI; Holmlund-Hampf JC; Furu PT; Heikkilä JE; Hinkkanen AE
Biochem Biophys Res Commun; 2007 Apr; 355(3):776-81. PubMed ID: 17316567
[TBL] [Abstract][Full Text] [Related]
15. A herpes simplex virus-derived replicative vector expressing LIF limits experimental demyelinating disease and modulates autoimmunity.
Nygårdas M; Paavilainen H; Müther N; Nagel CH; Röyttä M; Sodeik B; Hukkanen V
PLoS One; 2013; 8(5):e64200. PubMed ID: 23700462
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells.
Han D; Tian Y; Zhang M; Zhou Z; Lu J
Gene Ther; 2007 Mar; 14(5):383-95. PubMed ID: 17066098
[TBL] [Abstract][Full Text] [Related]
17. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination.
Furlan R; Poliani PL; Galbiati F; Bergami A; Grimaldi LM; Comi G; Adorini L; Martino G
Hum Gene Ther; 1998 Nov; 9(17):2605-17. PubMed ID: 9853527
[TBL] [Abstract][Full Text] [Related]
19. Regulation of autoimmune encephalomyelitis by toll-like receptors.
Marta M; Meier UC; Lobell A
Autoimmun Rev; 2009 May; 8(6):506-9. PubMed ID: 19211042
[TBL] [Abstract][Full Text] [Related]
20. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease.
Cua DJ; Hinton DR; Stohlman SA
J Immunol; 1995 Oct; 155(8):4052-9. PubMed ID: 7561116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
